Natural Biocon (India) Limited (BOM:543207)
India · Delayed Price · Currency is INR 3.580
+0.060 (1.70%)
At close: Sep 4, 2026
Natural Biocon (India) Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 92 | 84 | 383 | 116 | 53 | 103 | |
Market Cap Growth | -53.75% | -78.10% | 229.51% | 120.04% | -48.67% | -42.09% |
Enterprise Value | 96 | 85 | 377 | 116 | 52 | 103 |
Last Close Price | 3.58 | 3.25 | 14.84 | 10.21 | 4.64 | 9.04 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | 857.35 | 76.07 | 29.46 | 156.01 |
PS Ratio | 10.49 | 3.29 | 4.58 | 0.86 | 4.21 | 21.34 |
PB Ratio | 0.30 | 0.27 | 1.20 | 0.94 | 0.43 | 0.85 |
P/TBV Ratio | 0.30 | 0.27 | 1.20 | 0.94 | 0.43 | 0.85 |
P/FCF Ratio | 750.43 | 681.25 | 29.51 | - | 25.08 | 52.97 |
P/OCF Ratio | 318.28 | 288.95 | 29.51 | - | 25.08 | 52.97 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 10.87 | 3.33 | 4.51 | 0.85 | 4.18 | 21.31 |
EV/EBITDA Ratio | - | - | 617.17 | - | - | - |
EV/EBIT Ratio | - | - | 622.85 | 51.08 | 21.10 | 115.76 |
EV/FCF Ratio | 777.73 | 689.89 | 29.06 | - | 24.89 | 52.90 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Debt / EBITDA Ratio | - | - | 4.64 | - | - | - |
Debt / FCF Ratio | - | 30.53 | 0.22 | - | 0.73 | 0.84 |
Net Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | -0.01 | -0.02 | 0.00 |
Net Debt / EBITDA Ratio | -1.80 | -9.18 | 3.90 | - | - | - |
Net Debt / FCF Ratio | - | 27.30 | 0.18 | 0.98 | -1.17 | -0.24 |
Asset Turnover | - | 0.07 | 0.30 | 0.89 | 0.10 | 0.04 |
Inventory Turnover | - | - | 45.17 | 23.52 | 1.81 | 5.21 |
Quick Ratio | - | 0.85 | 0.86 | 1.16 | 0.80 | 2.97 |
Current Ratio | - | 0.86 | 1.06 | 1.46 | 1.67 | 3.94 |
Return on Equity (ROE) | - | -0.13% | 0.20% | 1.24% | 1.47% | 0.55% |
Return on Assets (ROA) | - | -0.07% | 0.14% | 0.93% | 1.20% | 0.45% |
Return on Invested Capital (ROIC) | -0.61% | -0.13% | 0.20% | 1.26% | 1.50% | 0.55% |
Return on Capital Employed (ROCE) | - | -0.10% | 0.20% | 1.80% | 2.00% | 0.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -2.06% | -0.48% | 0.12% | 1.31% | 3.39% | 0.64% |
FCF Yield | 0.13% | 0.15% | 3.39% | -1.07% | 3.99% | 1.89% |
Buyback Yield / Dilution | - | 4.67% | -84.47% | - | - | - |
Total Shareholder Return | - | 4.67% | -84.47% | - | - | - |